Table of Contents

About the EditorPreface Contributors to Volume IIPart 1. Antipsychotic polypharmacy 1. Antipsychotic polypharmacy for schizophrenia: 'Secret sauce' or 'wild abandon'? Peter F. Buckley2. Antipsychotic polypharmacy in USA. Anand K. Pandurangi, John Vernon3. Antipsychotic polypharmacy in Czech Republic and in Ukraine. Viktor P. Samokhvalov, Oxana Samokhvalova, Viktoria A. Verbenko, Georgij N. Verbenko4. Antipsychotic polypharmacy in residential facilities in Italy: the gap between recommendations and real world practice. Lucio Ghio, Werner Natta, Simona Gotelli, Luigi Ferrannini5. Antipsychotic polypharmacy and associated phenomena in patients with schizophrenia: Rational or irrational? KH Yong, Norman Sartorius, Kang Sim6. Antipsychotic polypharmacy in schizophrenia. How to counteract this common practice? Takefumi Suzuki, Hiroyuki Uchida, Koichiro Watanabe, Masaru Mimura 7. Clozapine combinations in treatment-resistant schizophrenia patients. Vladimir Lerner and Chanoch Miodownik8. Metabolic syndrome and antipsychotic polypharmacy. Fuminari Misawa, Fujii Yasuo, Yasuyuki Okumura, Hiroto Ito Part 2. Polypharmacy for other psychiatric conditions9. Evidence based combination therapy for bipolar disorder. Stamatia Magiria, Melina Siamouli, Xenia Gonda, Apostolos Iacovides, Konstantinos N. Fountoulakis10. Antidepressant combination strategies for major depressive disorder. Andre F. Carvalho, Danielle S. Macedo, Thomas N. Hyphantis, Roger S. McIntyre11. Herbal remedies and nutraceuticals as augmentation or adjunct for mood and anxiety disorders: evidence for benefit and risk. Arun V. Ravindran and Tricia L. da Silva12. Obsessive-compulsive syndromes in schizophrenia: A case for polypharmacy? Frederike Schirmbeck and Mathias Zink

13. Polypharmacy and potentially inappropriate medication use among elders with dementia. Jan Luzny14. The role of polypharmacy in bipolar disorder treatment guidelines. Heinz GrunzeAppendix Rena Kurs1. Annotated bibliography on polypharmacy2. List of Psychotropic Medications Contents to Volume I Contributors to Volume IIndex

Reviews

From the reviews:

"The intent is to bring together a compendium of information from both clinical research and experience regarding the ever-increasing use of polypharmacy in the treatment of psychiatric conditions. ... should be read by anyone involved in the pharmacological management of psychiatric illnesses." (Michael Easton, Doody's Book Reviews, July, 2013)